SCHEMBL1334869

SCHEMBL1334869

Cc1ccc(Nc2ccc(C)cc2C)c(C)c1

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 3/20 0.74
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
SMN1; SMN2 Q16637 6/20 0.53
LMNA P02545 3/20 0.51
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
MAPK1 P28482 2/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
ALDH1A1 P00352 3/20 0.48
HTT P42858 2/20 0.48
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
TP53 P04637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30320262 1.00 RAPGEF4 (0.74) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL22814342 0.91 RAPGEF4 (0.63) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL1921160 0.91 RAPGEF4 (0.63) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7866844 0.91 RAPGEF4 (0.63) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL30575353 0.89 RAPGEF4 (0.61) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL8598906 0.89 RAPGEF4 (0.61) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL29445703 0.87 RAPGEF4 (0.65) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL1921159 0.87 RAPGEF4 (0.65) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL21776018 0.87 RAPGEF4 (0.59) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7003942 0.87 RAPGEF4 (0.64) RAPGEF4MEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261403-B2 Stabilized compositions comprising leuco compounds MILLIKEN & COMPANY (US) 2022-03-01 US claimed
US-11136535-B2 Leuco colorants as bluing agents in laundry care compositions THE PROCTER & GAMBLE COMPANY (US) 2021-10-05 US claimed
EP-3830232-A1 LEUCO COLORANTS AS BLUING AGENTS IN LAUNDRY CARE COMPOSITIONS The Procter & Gamble Company (US) 2021-06-09 EP claimed
WO-2020023812-A1 LEUCO COLORANTS AS BLUING AGENTS IN LAUNDRY CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2020-01-30 WO claimed
US-20200032167-A1 STABILIZED COMPOSITIONS COMPRISING LEUCO COMPOUNDS MILLIKEN & COMPANY 2020-01-30 US claimed
US-20200032173-A1 LEUCO COLORANTS AS BLUING AGENTS IN LAUNDRY CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2020-01-30 US claimed
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics DOTTIKON ES HOLDING AG (CH) 2024-10-22 US disclosed
US-12091553-B2 Core-shell dye, near-infrared absorbing composition including the same, and near-infrared absorbing film SAMSUNG SDI CO., LTD. (KR) 2024-09-17 US disclosed
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 EP disclosed
US-11944010-B2 Organic electroluminescent device KYULUX, INC. (JP) 2024-03-26 US disclosed
US-20230392018-A1 COMPOSITIONS COMPRISING LEUCO COMPOUNDS AND COLORANTS MILLIKEN & COMPANY 2023-12-07 US disclosed
US-20230348724-A1 CORE-SHELL DYE, NEAR-INFRARED ABSORBING COMPOSITION INCLUDING THE SAME, AND NEAR-INFRARED ABSORBING FILM SAMSUNG SDI CO., LTD. (KR) 2023-11-02 US disclosed
WO-2023190472-A1 CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME 公益財団法人相模中央化学研究所 2023-10-05 WO disclosed
WO-2004011692-A2 PROCESS FOR PREPARING DIHYDROCARBYLAMINO METAL COMPOUNDS ALBEMARLE CORPORATION (US) 2004-02-05 WO disclosed
US-20020048710-A1 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2002-04-25 US disclosed
US-4558101-A FROM HYDROCARBON POLYMER CONTAINING OLEFINIC GROUPS WITH HYDROGEN CARBON MONOXIDE AND AMINE USING GROUP 8 METAL CATALYST W. R. GRACE & CO. (US) 1985-12-10 US disclosed
US-4526936-A Reacting polymeric hydrocarbon, primary or secondary amine, carbon monoxide, hydrogen, in the presence of group VIII metal catalyst W. R. GRACE & CO. (US) 1985-07-02 US disclosed
US-4375560-A Process for the preparation of 3,5-dimethylaniline (sym. m-xylidine) HOECHST AKTIENGESELLSCHAFT (DE) 1983-03-01 US disclosed
US-4375561-A Process for the preparation of aromatic amines HOECHST AKTIENGESELLSCHAFT (DE) 1983-03-01 US disclosed
US-4312965-A Process for forming amine/amide containing polymers W. R. GRACE & CO. (US) 1982-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics NR0B2, KCNJ2, TRRAP RAPGEF4 2355/4885MEN1 2154/4885KMT2A 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.